Jane Huang - President, CMO at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CMO
Issuer Symbol
PRLD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jane Huang since 03 Feb 2025

Holdings reported by Jane Huang for Prelude Therapeutics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 86,917 $127,767 $1.47 04 Oct 2025 Direct
Restricted Stock Unit 18,750 $25,969 $0.6925 04 Oct 2025 Direct Common Stock
Employee Stock Option (right to buy) 200,000 04 Feb 2025 Direct Common Stock

Transactions reported by Jane Huang for Prelude Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.